Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer

NCT07041437 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: SHR-A2102
DRUG: Adebrelimab

Sponsor

Fudan University